C3.ai 4Q26 Preliminary Results: Revenue Down 53%, Siebel Back as CEO – Turnaround Hurdles Remain

Core Conclusion

C3.ai's preliminary 4Q26 revenue of $51.6 million (-53% YoY) was modestly above consensus but masked deteriorating sales execution: bookings missed expectations, signed agreements collapsed to 28 (from 44 in 3Q26), and FY26 full-year revenue fell 35.7% to $250.3 million. Thomas Siebel's return as CEO on May 8 does not address the core issue—a structurally impaired sales engine that has now produced three consecutive quarters of accelerating revenue decline. The restructuring plan's $135 million in annualized cost savings is insufficient against FY26 operating losses of $217.8 million. With a $6.00 price target (37% downside from $9.48), the risk/reward remains unfavorable.

Revenue Decline Is Structural, Not Cyclical

Revenue erosion accelerated through FY26. 4Q26 revenue of $51.6 million was down 53% YoY, worse than 3Q26's 38% decline and 2Q26's 28% drop. Full-year revenue of $250.3 million represents a $139 million absolute decline from FY25's $389 million. The trajectory shows no stabilization: quarterly revenue has fallen sequentially from $70.7M in 1Q26 to $61.6M, $66.4M, and now $51.6M.

New business generation is deteriorating. Signed agreements dropped from 44 in 3Q26 to 28 in 4Q26, including only 9 new Initial Production Deployments and 7 IDP conversions. Bookings came in below expectations. At current run rates, even if stabilization occurs in FY27, the revenue base will be materially below $200 million.

Investment implication: The implied FY27 revenue range ($180-210M) using rough extrapolation would represent another 20-30% decline from FY26. At these levels, fixed cost leverage becomes negative, and the path to operating breakeven extends further into FY28 or beyond.

Restructuring Savings Cannot Bridge the Loss Gap

Cost reduction is underway but insufficient by a wide margin. The restructuring plan is largely complete and expected to deliver ~$135 million in annualized non-GAAP cost savings, with full benefits in 2HFY27. However, FY26 non-GAAP operating losses totaled $217.8 million (margin -87%). Even assuming $135 million in savings materializes fully, the implied run-rate operating loss would be ~$83 million annually, requiring continued cash burn.

4Q26 non-GAAP operating loss was $54.4 million (-105% margin), modestly better than guidance (($64M)-($56M)) but still representing negative operating leverage on a declining revenue base. The company ended FY26 with $575.4 million in cash and investments.

Investment implication: At current burn rates (~$55M/quarter operating loss), cash provides roughly 10-11 quarters of runway. Revenue stabilization—not just cost cuts—is required to avoid equity dilution or accelerated restructuring. The $135 million savings figure is already largely priced in, but the missing variable is revenue inflection.

CEO Change Does Not Fix Sales Execution

Siebel's return is not a structural fix. Thomas Siebel resumed CEO on May 8, replacing Stephen Ehikian who held the role for only 7 months. While Siebel stated his vision "remains impaired but improving," the market should question whether the founder can re-accelerate sales after three years of consecutive revenue decline. Ehikian remains President, reporting to Siebel—an unchanged organizational structure for the sales function.

Sales execution is the binding constraint. The company signed 28 agreements in 4Q26 vs. 44 in 3Q26, showing that leadership instability (three CEOs in 12 months) has directly impacted deal velocity. No new partnership accelerants were cited in the pre-announcement.

Investment implication: Management changes without addressing product-market fit, customer concentration, or competitive positioning are unlikely to reverse the revenue trajectory. Siebel's track record in the current lower-revenue, smaller-deal environment remains unproven.

Key Risks

Upside risks: Baker Hughes partnership ramps faster than expected, expanding customer base. Gen AI Suite drives downstream market penetration. Revenue decline stabilizes sooner.

Downside risks: Customer concentration remains high—single-client losses could accelerate decline. Cloud providers (AWS, Azure) and AI/ML competitors (Palantir, others) continue capturing market share. No evidence of sales force stabilization.

Valuation and Trade Implication

Target price of $6.00 implies 37% downside. The valuation uses 15x CY34 free cash flow per share of $0.35 ($81 million at 20% margin), discounted at ~13% WACC to CY27. This assumes revenue stabilization by FY28 and margin recovery to 20% by CY34—a base case that requires significant execution improvement. Even with optimistic assumptions, the DCF yields a target well below the current $9.48 close.

Maintain Underweight. The risk/reward is asymmetric: a 37% downside to target versus limited upside catalysts. Siebel's return may create temporary sentiment lift, but the underlying revenue decline and cash burn trajectory argue for continued underperformance. The path to positive free cash flow remains multiple years out.

Appendix

C3.ai Quarterly Revenue & Agreement Trend (FY25-FY26)